At the news
? NEUTRALIMPACT 2/10 CLUSTER filed Jul 7, 2026 at 16:15 ET
Three Vertex EVPs sold a total of $1.49M in stock over a one-week period ending July 2, 2026, representing less than 0.001% of the company's $134.4B market cap. The sales occurred just before Vertex announced a $10B acquisition of Crinetics Pharmaceuticals on July 7, but the dollar amounts are immaterial and likely reflect routine portfolio management or pre-planned 10b5-1 transactions.
- Three EVPs (Chief Regulatory & Quality Officer, CMO, Chief Legal Officer) sold shares between June 25 and July 2, 2026.
- Total sales value: $1.49M, or ~0.0011% of Vertex's $134.4B market cap.
- Sales occurred before the July 7 announcement of a $10B acquisition of Crinetics Pharmaceuticals.
- All transactions were open-market sales (code S).
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access